Federated Hermes
RLYB icon

Federated Hermes’s Rallybio RLYB Stock Holding History

Federated Hermes’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-276
Closed -$747 – 2212
2025
Q2 		$747 Hold
276
– – ﹤0.01% 2016
2025
Q1 		$1.45K Sell
276
-473
-63% -$2.99K ﹤0.01% 1977
2024
Q4 		$5.75K Sell
749
-247
-25% -$2.07K ﹤0.01% 1888
2024
Q3 		$9.32K Buy
996
+219
+28% +$2.11K ﹤0.01% 1812
2024
Q2 		$8.33K Buy
777
+560
+258% +$7.59K ﹤0.01% 1796
2024
Q1 		$3.21K Buy
+217
New +$3.02K ﹤0.01% 1878
2023
Q4 		– Sell
-6
Closed -$152 – 2182
2023
Q3 		$152 Buy
+6
New +$260 ﹤0.01% 2075

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return

Federated Hermes's RLYB Position: Q3 2025 in Review

Federated Hermes sold out of Rallybio (RLYB) in Q3 2025, closing a stake of 276 shares — an estimated $747 sold.

Federated Hermes first reported a position in RLYB in Q3 2023 and held it in 7 quarters. The position peaked at $9.32K in Q3 2024. 45 funds tracked by Wall St. Rank hold RLYB as of Q3 2025.

  • Federated Hermes reported no remaining Rallybio position as of Q3 2025 after selling out during the quarter.
  • Federated Hermes sold 276 Rallybio shares in Q3 2025, an estimated $747.
  • Federated Hermes first reported a position in Rallybio in Q3 2023 and held it in 7 quarters.
  • Federated Hermes's Rallybio position peaked at $9.32K in Q3 2024.
  • 45 funds tracked by Wall St. Rank held Rallybio as of Q3 2025.

Based on Federated Hermes's 13F filing for Q3 2025, filed 3 Nov 2025.